The Role of Entrepreneurial Activities in Academic Pharmaceutical Science Research

Por Stinchcomb, Audra L.
Publicado em 2010

Estimation of maximum transdermal flux of nonionized xenobiotics from basic physicochemical determinants

Por Milewski, Mikolaj, Stinchcomb, Audra L.
Publicado em 2012

Current Aspects of Formulation Efforts and Pore Lifetime Related to Microneedle Treatment of Skin

Por Milewski, Mikolaj, Brogden, Nicole K., Stinchcomb, Audra L.
Publicado em 2010

Effect of formulation pH on transport of naltrexone species and pore closure in microneedle-enhanced transdermal drug delivery

Por Ghosh, Priyanka, Brogden, Nicole K., Stinchcomb, Audra L.
Publicado em 2013

Optimization of Naltrexone Diclofenac Codrugs for Sustained Drug Delivery Across Microneedle-Treated Skin

Por Ghosh, Priyanka, Lee, DoMin, Kim, Kyung Bo, Stinchcomb, Audra L.
Publicado em 2013

Transdermal Delivery of Cannabidiol Attenuates Binge Alcohol-Induced Neurodegeneration in a Rodent Model of an Alcohol Use Disorder

Por Liput, Daniel J., Hammell, Dana C., Stinchcomb, Audra L., Nixon, Kimberly
Publicado em 2013

Synthesis and in vitro stability of amino acid prodrugs of 6-β-naltrexol for microneedle-enhanced transdermal delivery

Por Eldridge, Joshua A., Milewski, Mikolaj, Stinchcomb, Audra L., Crooks, Peter A.
Publicado no Bioorg Med Chem Lett (2014)

Binge Alcohol Exposure Transiently Changes the Endocannabinoid System: A Potential Target to Prevent Alcohol-Induced Neurodegeneration

Por Liput, Daniel J., Pauly, James R., Stinchcomb, Audra L., Nixon, Kimberly
Publicado no Brain Sci (2017)

Diclofenac enables unprecedented week-long microneedle-enhanced delivery of a skin impermeable medication in humans

Por Brogden, Nicole K., Banks, Stan L., Crofford, Leslie J., Stinchcomb, Audra L.
Publicado em 2013

Simultaneous Quantification of Anandamide and Other Endocannabinoids in Dorsal Vagal Complex of Rat Brainstem by LC-MS

Por Chen, Jing, Paudel, Kalpana S., Derbenev, Andrei V., Smith, Bret N., Stinchcomb, Audra L.
Publicado em 2009

IN VITRO PERMEATION OF A PEGYLATED NALTREXONE PRODRUG ACROSS MICRONEEDLE-TREATED SKIN

Por Milewski, Mikolaj, Yerramreddy, Thirupathi Reddy, Ghosh, Priyanka, Crooks, Peter A., Stinchcomb, Audra L.
Publicado em 2010

Development of in vivo impedance spectroscopy techniques for measurement of micropore formation following microneedle insertion

Por Brogden, Nicole K., Ghosh, Priyanka, Hardi, Lucia, Crofford, Leslie J., Stinchcomb, Audra L.
Publicado em 2013

Programmable transdermal drug delivery of nicotine using carbon nanotube membranes

Por Wu, Ji, Paudel, Kalpana S., Strasinger, Caroline, Hammell, Dana, Stinchcomb, Audra L., Hinds, Bruce J.
Publicado em 2010

Carbon Nanotube Membranes for use in the Transdermal Treatment of Nicotine Addiction and Opioid Withdrawal Symptoms

Por Strasinger, Caroline L., Scheff, Nicole N., Wu, Ji, Hinds, Bruce J., Stinchcomb, Audra L.
Publicado em 2009

Diclofenac Enables Prolonged Delivery of Naltrexone Through Microneedle-Treated Skin

Por Banks, Stan L., Paudel, Kalpana S., Brogden, Nicole K., Loftin, Charles D., Stinchcomb, Audra L.
Publicado em 2011

Novel 3-O-pegylated carboxylate and 3-O-pegylated carbamate prodrugs of naltrexone for microneedle-enhanced transdermal delivery

Por Yerramreddy, Thirupathi Reddy, Milewski, Mikolaj, Penthala, Narsimha Reddy, Stinchcomb, Audra L., Crooks, Peter A.
Publicado em 2010

In Vitro Skin Diffusion Study of Pure Forskolin versus a Forskolin-Containing Plectranthus barbatus Root Extract

Por Chen, Jing, Hammell, Dana C., Spry, Malinda, D’Orazio, John A., Stinchcomb, Audra L.
Publicado no J Nat Prod (2009)

Characterization of the permeability barrier of human skin in vivo

Por Pirot, Fabrice, Kalia, Yogeshvar N., Stinchcomb, Audra L., Keating, Garrett, Bunge, Annette, Guy, Richard H.
Publicado em 1997

Challenges and opportunities in dermal/transdermal delivery

Por Paudel, Kalpana S, Milewski, Mikolaj, Swadley, Courtney L, Brogden, Nicole K, Ghosh, Priyanka, Stinchcomb, Audra L
Publicado em 2010

Pharmacokinetic and pharmacodynamic profile of supratherapeutic oral doses of Δ(9)-THC in cannabis users

Por Lile, Joshua A., Kelly, Thomas H., Charnigo, Richard J., Stinchcomb, Audra L., Hays, Lon R.
Publicado em 2013